Sort
30,917 grants matching “tumor microenvironment”
A novel preclinical model of spontaneous metastasis
$412,046Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Antagonistic role of ARF and ADAR1 in triple-negative breast cancer
$412,015Jason Weber · Washington University · R01 · FY2023 · CA
Mechanisms of cellular crosstalk in tumor-promoting niche formation
$411,981Naoki Oshimori · Oregon Health & Science University · R01 · FY2023 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$411,930Arvind P Pathak · Johns Hopkins University · R01 · FY2023 · CA
New Bioreactor-based approach to stem cell/progenitor expansion for cell therapie
$411,899Stephen Samuel Navran · Synthecon, Inc. · R44 · FY2010 · HD
Project 2: Effect of HTLV-1 Viral Oncogenes on the Bone Microenvironment during tumor growth and progression in ATL
$411,872Deborah V Novack · Ohio State University · P01 · FY2024 · CA
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
$411,831Edna Cukierman · Research Inst Of Fox Chase Can Ctr · U54 · FY2023 · CA
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$411,790Melissa L Fishel · Indiana University Indianapolis · R01 · FY2024 · CA
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
$411,778Elizabeth A. Platz · Johns Hopkins University · R01 · FY2023 · CA
Stromal senescence in lethal prostate cancer: a novel target for prognosis and therapy
$411,778Elizabeth A. Platz · Johns Hopkins University · R01 · FY2022 · CA
Molecular Imaging of Metabolic Switches in Malignant Transformations
$411,756Heather Christofk · California Institute Of Technology · U54 · FY2012 · CA
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2023 · NS
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2021 · NS
Targeting of Mitochondrial Lon Protease as a Novel Therapy for Glioblastoma
$411,688Daniela Annenelie Bota · University Of California-Irvine · R01 · FY2022 · NS
HORMONE REGULATION OF TUMOR MICROENVIRONMENT IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER BY EXTRACELLULAR VESICLE MICRORNAS
$411,659The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
AIDS and Cancer Specimen Resource (ACSR)
$411,640Jeffrey M Bethony · George Washington University · UM1 · FY2025 · CA
WEE1 inhibition and tumor immunity
$411,600Bin Zhang · Northwestern University At Chicago · R01 · FY2022 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$411,598Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2021 · CA
Project 2: Cytoplasmic chromatin fragments (CCF) as a driver of liver cancer and target for intervention during aging
$411,553Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2023 · AG
ANTIBODY-TARGETED IMMUNOTHERAPY OF CANCER
$411,489Fox Chase Cancer Center · R01 · FY2001 · CA
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
$411,480Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2023 · CA
Project 1: Targeting Tumor Phospholipase PLA2G10 for Cancer Immunotherapy
$411,417Kurt A Schalper · Yale University · P50 · FY2025 · CA
GENES WITH SIGNIFICANT DEFICIT OF LOSS-OF-FUNCTION MUTATIONS IN LUNG TUMOR
$411,404Ivan P Gorlov · Baylor College Of Medicine · R21 · FY2025 · CA
Adipocyte regulation of tumor survival in metastatic prostate cancer: new targets for therapy
$411,377Izabela Podgorski · Wayne State University · R01 · FY2020 · CA
Lifestyle associated reactive metabolites and their negative impact on breast cancer risk
$411,365Victoria Jane Findlay · Medical University Of South Carolina · R01 · FY2021 · CA